Ying and Yang of Ceramide in the Vascular Endothelium
Arteriosclerosis, Thrombosis, and Vascular Biology · 2024
DOI: 10.1161/atvbaha.124.321158 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2024. Verfasst von Gopika SenthilKumar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology (G.S., Z.Z., B.K., A.M.J., C.G.S., R.H.L., J.K.F.), Medical College of Wisconsin, Milwaukee. Hauptthemen laut MEDLINE: Ceramides, Endothelium, Vascular, Oxidative Stress, Cardiovascular Diseases. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Ceramides, a group of biologically active sphingolipids, have been described as the new cholesterol given strong evidence linking high plasma ceramide with endothelial damage, risk for early adverse cardiovascular events, and development of cardiometabolic disease. This relationship has sparked great interest in investigating therapeutic targets with the goal of suppressing ceramide formation. However, the growing data challenge this paradigm of ceramide as solely eliciting detrimental effects to the cardiovascular system. Studies show that ceramides are necessary for maintaining proper endothelial redox states, mechanosensation, and membrane integrity. Recent work in preclinical models and isolated human microvessels highlights that the loss of ceramide formation can in fact propagate vascular endothelial dysfunction. Here, we delve into these conflicting findings to evaluate how ceramide may be capable of exerting both beneficial and damaging effects within the vascular endothelium. We propose a unifying theory that while basal levels of ceramide in response to physiological stimuli are required for the production of vasoprotective metabolites such as S1P (sphingosine-1-phosphate), the chronic accumulation of ceramide can promote activation of pro-oxidative stress pathways in endothelial cells. Clinically, the evidence discussed here highlights the potential challenges associated with therapeutic suppression of ceramide formation as a means of reducing cardiovascular disease risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology (G.S., Z.Z., B.K., A.M.J., C.G.S., R.H.L., J.K.F.), Medical College of Wisconsin, Milwaukee.
- Department of Physiology (G.S., R.H.L., J.K.F.), Medical College of Wisconsin, Milwaukee.
- Cardiovascular Center (G.S., Z.Z., K.E.C., B.K., A.M.J., C.G.S., R.H.L., J.K.F.), Medical College of Wisconsin, Milwaukee.
- and Division of Cardiovascular Medicine, Department of Medicine (K.E.C.), Medical College of Wisconsin, Milwaukee.
ORCID-Profile: Gopika SenthilKumar, Zachary Zirgibel, Rachel H Limpert, Julie K Freed
Förderung
- NHLBI NIH HHS
Zitieren
APA
SenthilKumar, G., Zirgibel, Z., Cohen, K. E., Katunaric, B., Jobe, A. M., Shult, C. G., Limpert, R. H., & Freed, J. K. (2024). Ying and Yang of Ceramide in the Vascular Endothelium. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.124.321158
Vancouver
SenthilKumar G, Zirgibel Z, Cohen KE, Katunaric B, Jobe AM, Shult CG, et al. Ying and Yang of Ceramide in the Vascular Endothelium. Arteriosclerosis, Thrombosis, and Vascular Biology. 2024. doi:10.1161/atvbaha.124.321158
BibTeX
@article{SenthilKumar2024,
author = {SenthilKumar, Gopika and Zirgibel, Zachary and Cohen, Katie E and Katunaric, Boran and Jobe, Alyssa M and Shult, Carolyn G and Limpert, Rachel H and Freed, Julie K},
title = {Ying and Yang of Ceramide in the Vascular Endothelium},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2024},
doi = {10.1161/atvbaha.124.321158}
}
EUVIMED